Conjugated Estrogens Tablet, Film Coated
Product Images NDC 66993-299

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Conjugated Estrogens (NDC 66993-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Conjugated Estrogens 01)

A cumulative distribution plot showing the percent change from baseline in spine bone mineral density (BMD) among subjects. The chart compares four groups: 0.625 mg, 0.45 mg, 0.3 mg of conjugated estrogens, and placebo. The x-axis represents the percent change from baseline in spine BMD, ranging from positive to negative values, while the y-axis shows the cumulative percent of subjects.*

FDA Label Image

Figure 2 (Conjugated Estrogens 02)

A line graph depicting adjusted percent change from baseline versus treatment cycle for Conjugated Estrogens at strengths 0.3 mg, 0.45 mg, 0.625 mg, and placebo groups. The x-axis represents treatment cycles from 0 to 26, and the y-axis shows adjusted percent change from baseline from -4% to 5%. Each strength group is represented by a distinct line with error bars.*

FDA Label Image

Prasco Logo (Conjugated Estrogens 03)

Conjugated Estrogens film-coated tablets in various strengths (0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg, 1.25 mg per tablet) manufactured by Prasco Laboratories. The image shows multiple white plastic prescription bottles with labels listing the product name, strength, NDC codes, barcodes, and manufacturer details.*

FDA Label Image

Prasco Logo (Conjugated Estrogens 04)

Conjugated Estrogens tablets, film-coated, in a carton labeled with the Prasco Laboratories logo. The package shows the proprietary name 'Conjugated Estrogens' and indicates several available tablet strengths, including 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg, and 1.25 mg per tablet. The label confirms the oral route of administration and identifies the product as a human prescription drug.*

FDA Label Image

Principal Display Panel (0.45 mg Tablet Bottle Label)

Label for Conjugated Estrogens Tablets, USP 0.45 mg film-coated tablets by Prasco Laboratories. The label indicates a package of 100 tablets for prescription use only, with storage instructions and manufacturer information from Mason, OH. Includes barcode and NDC 66993-296-02.*

FDA Label Image

Principal Display Panel (0.625 mg Tablet Bottle Label)

Label for Conjugated Estrogens Tablets, USP 0.625 mg, film-coated oral tablets. The label indicates the product is prescription only and contains 100 tablets per package. It is distributed by Prasco Laboratories, Mason, OH, USA, and made in Canada. Storage instructions specify 20° to 25°C with permitted excursions. Additional dispensing and dosage information is referenced on accompanying literature.*

FDA Label Image

Principal Display Panel (1.25 mg Tablet Bottle Label)

Label for Conjugated Estrogens Tablets, USP 1.25 mg by Prasco Laboratories. The label indicates a package size of 100 tablets, prescription only. Storage instructions specify a temperature range of 20° to 25°C with permitted excursions. The label includes dispensing instructions and a barcode with NDC 66993-299-02.*

FDA Label Image

Principal Display Panel (0.3 mg Tablet Bottle Label)

Label for Conjugated Estrogens Tablets USP 0.3 mg by Prasco Laboratories. The label shows the tablet strength as 0.3 mg, indicates 100 tablets per package, and displays storage instructions and dispensing information. The label also includes the NDC number 66993-295-02 and a barcode.*

FDA Label Image

Principal Display Panel (0.9 mg Tablet Bottle Label)

Label for Conjugated Estrogens Tablets, USP 0.9 mg by Prasco Laboratories. The label indicates 100 film-coated tablets packaged for oral use. It includes storage instructions from 20° to 25°C with permitted excursions, dispensing information, and denotes it as prescription only (Rx only). The label shows product NDC 66993-298-02 and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.